NASDAQ:PRCPPerceptron Stock Price, Forecast & News

Perceptron's stock was trading at $4.05 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PRCP shares have decreased by 19.3% and is now trading at $3.27. View which stocks have been most impacted by Coronavirus.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perceptron in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Perceptron.

Perceptron is scheduled to release its next quarterly earnings announcement on Wednesday, September 2nd 2020. View our earnings forecast for Perceptron.

Perceptron, Inc. (NASDAQ:PRCP) posted its quarterly earnings data on Monday, June, 1st. The scientific and technical instruments company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.33. The scientific and technical instruments company had revenue of $12.67 million for the quarter, compared to analyst estimates of $15.63 million. Perceptron had a negative net margin of 16.08% and a negative return on equity of 1.29%. View Perceptron's earnings history.

1 equities research analysts have issued 1-year target prices for Perceptron's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Perceptron's stock price to reach $2.00 in the next year. This suggests that the stock has a possible downside of 38.8%. View analysts' price targets for Perceptron.

Press coverage about PRCP stock has trended very negative recently, according to InfoTrie. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Perceptron earned a news impact score of -3.3 on InfoTrie's scale. They also gave news stories about the scientific and technical instruments company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about Perceptron.

Perceptron saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 41,300 shares, a decline of 6.1% from the May 31st total of 44,000 shares. Based on an average daily volume of 53,100 shares, the short-interest ratio is presently 0.8 days. Approximately 0.4% of the shares of the stock are short sold. View Perceptron's Current Options Chain.

Some companies that are related to Perceptron include KLA (KLAC), II-VI (IIVI), Nova Measuring Instruments (NVMI), Topcon (TOPCF), Camtek (CAMT), CyberOptics (CYBE), Optex Systems Hldg InCorp (OPXS) and ProPhotonix (STKR). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Perceptron investors own include NVIDIA (NVDA), Inseego (INSG), Niu Technologies (NIU), Crispr Therapeutics (CRSP), Baozun (BZUN), Marvell Technology Group (MRVL), InVitae (NVTA), Baidu (BIDU), iCAD (ICAD) and IMPINJ (PI).

Perceptron trades on the NASDAQ under the ticker symbol "PRCP."

Shares of PRCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRCP stock can currently be purchased for approximately $3.27.

Perceptron has a market capitalization of $31.78 million and generates $76.82 million in revenue each year. The scientific and technical instruments company earns $-6,790,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. Perceptron employs 337 workers across the globe.

The official website for Perceptron is www.perceptron.com.

Perceptron's mailing address is 47827 HALYARD DRIVE, PLYMOUTH MI, 48170. The scientific and technical instruments company can be reached via phone at 734-414-6100 or via email at [email protected]